The South African Health Products Regulatory Authority has approved the use of the Sinovac Covid-19 vaccine.
However, under certain conditions.
The approval is under Section 21 of the Medicines and Related Substance Act.
Individuals between the ages of 18 and 59 years can use the vaccine.
There are two doses that are administered 14 to 28 days apart.
One of the conditions is that Sinovac must submit the final results of ongoing clinical studies.
It also needs to submit periodic safety updates.
The Sinovac vaccine has a provisional shelf life of 24 months.
Source: eNCA
In other news – Muvhango actress and slay queen Tebogo Thobejane leaves South Africa
Muvhango actress and businesswoman Tebogo Thobejane has left the country to find greener pastures. Thobejane, who plays Belinda on the popular drama show was spotted on Wednesday night at the OR Tambo International Airport departures.
Sources close to her revealed she was traveling to North Africa. Learn More
The post SAHPRA approves the use of Sinovac COVID-19 vaccine appeared first on News365.co.za.
No comments:
Post a Comment